Recommended Pages at proactiveinvestors.com
AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug - Proactiveinvestors (NA)
proactiveinvestors.com — “AstraZeneca (NYSE:AZN) and Dynavax Technologies (NASDAQ:DVAX) announced Wednesday they have amended their collaboration agreement so as to accelerate the development of AZD1419, intended for the treatment of asthma.” View full resource at proactiveinvestors.com
Most Recently Shared on October 7, 2011 at 11:44 am By:
Michael Blaiss, MD Doctor, Allergist, and Physician
AstraZeneca, Dynavax amend agreement to accelerate development of asthma drug - http://t.co/R4pDQf4Z
Chelsea Therapeutics receives new US patent for Droxidopa drug - Proactiveinvestors (NA)
proactiveinvestors.com — “Chelsea Therapeutics (NASDAQ:CHTP) said on Tuesday that the U.S. Patent Office has issued a new patent for the use of drug Droxidopa to treat fibromyalgia, a chronic disorder characterized by widespread muscle pain, joint stiffness, and fatigue.” View full resource at proactiveinvestors.com
Most Recently Shared on September 6, 2011 at 5:37 pm By:
Chelsea Therapeutics receives new US patent for Droxidopa drug - Proactive Investors USA & Canada http://t.co/NOUJ743
International Stem Cell appoints marketing executive for Lifeline Skin Care subsidiary - Proactiveinvestors (NA)
proactiveinvestors.com — “California-based International Stem Cell Corp (OTC:ISCOE), a biotechnology company with a focus on therapeutic and biomedical research and cosmetic products, said on Thursday that Donna Queen has joined its executive team.” View full resource at proactiveinvestors.com
Most Recently Shared on June 16, 2011 at 9:44 pm By:
Shalona Anuj, PhD PhD, Doctor, Organic Advocate, and Skin and Beauty
International Stem Cell appoints marketing executive for Lifeline Skin Care ... http://bit.ly/ks85no
Positron to build high energy radiopharmaceutical facility in Indiana, focused on vertical expansion - Proactiveinvestors (NA)
proactiveinvestors.com — “The $55 million facility will be the largest US-based commercial cyclotron, a device used to make radioactive isotopes, which are in turn used to make radiopharmaceuticals, key tracers or imaging agents used in the field of nuclear medicine in the diagnosis and treatment of many diseases, such as those in cardiology and oncology.” View full resource at proactiveinvestors.com
Most Recently Shared on June 13, 2011 at 9:17 pm By:
Philips Medical News Health Business
Positron to build unique,high energy radiopharmaceutical facility in Indiana ... http://bit.ly/kGYhiL - #imaging
Exelixis and Ariad Pharmaceuticals set to shine at ASCO 2011
proactiveinvestors.com — “With ASCO 2011 around the corner, we wanted to overview two oncology companies that the market will be watching closely: Exelixis Inc.(NASDAQ: EXEL) and Ariad Pharmaceuticals (NASDAQ: ARIA).” View full resource at proactiveinvestors.com
Most Recently Shared on May 10, 2011 at 2:59 am By:
Paul Cacciatore Patient Advocate
Ovarian cancer drugs XL184 (MET & VEGFR2 inhibitor) & ridaforolimus (mTOR inhibitor) 2 B featured in "Best of ASCO 2011." http://dld.bz/ZrND
IntegraMed sees good growth potential for fertility and vein clinics - Proactiveinvestors (NA)
proactiveinvestors.com — “IntegraMed America (NASDAQ:INMD), an operator of fertility centers and vein care centers, reported on Thursday a 26% drop in fourth quarter profit, but per share earnings still bested analyst estimates by a penny.” View full resource at proactiveinvestors.com
Most Recently Shared on February 19, 2011 at 2:40 pm By:
Iva Keene, ND CAM and Naturopathic Doctor
IntegraMed sees good growth potential for fertility and vein clinics - Proactiveinvestors (NA) http://ht.ly/3YZYj #fertility #infertility
Proactive Investors NA - Inovio Pharmaceuticals' preclinical study on prostate cancer vaccine published in medical journal
proactiveinvestors.com — “Proactive Investors NA - Inovio Pharmaceuticals' preclinical study on prostate cancer vaccine published in medical journal” View full resource at proactiveinvestors.com
Most Recently Shared on February 2, 2011 at 6:39 pm By:
Inovio Pharmaceuticals' preclinical study on prostate cancer vaccine published ... http://bit.ly/geY9ZL
Proactive Investors NA - ISTA Pharmaceuticals reports preliminary positive results for seasonal allergy nasal spray
proactiveinvestors.com — “Proactive Investors NA - ISTA Pharmaceuticals reports preliminary positive results for seasonal allergy nasal spray” View full resource at proactiveinvestors.com
Most Recently Shared on October 6, 2010 at 4:15 pm By:
ISTA Pharmaceuticals reports preliminary positive results for seasonal allergy ... http://bit.ly/a0Upjc
Proactive Investors NA - Celera signs distribution agreement for diagnostic coronary heart disease test with Abbott
proactiveinvestors.com — “Proactive Investors NA - Celera signs distribution agreement for diagnostic coronary heart disease test with Abbott” View full resource at proactiveinvestors.com
Most Recently Shared on September 20, 2010 at 3:57 pm By:
low sodium foods Health Business
Celera signs distribution agreement for diagnostic coronary heart disease test ... - Proactive Investors USA & Canada http://bit.ly/bLMZBQ
